🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, single-arm, single-center Phase Ib/II study to explo...
Status
Completed
Location
National Cancer Center Hospital East
Start Date
2022-06-06
Trial ID
NCT05394740
Treatments Being Tested
This is a multi-site, three-cohort phase II trial of cabozantinib for IMDC ...
Status
Recruiting
Location
Fox Chase Cancer Center
Start Date
2022-01-21
Trial ID
NCT05263050
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and eff...
Status
Completed
Location
The University of Alabama Birmingham (UAB)
Start Date
2017-10-09
Trial ID
NCT03241173
Treatments Being Tested
The purpose of this study is to closely examine tumor and blood samples fro...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2015-01-20
Trial ID
NCT02350764
The purpose of this study is to evaluate the safety and efficacy of the com...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12-15
Trial ID
NCT03342352
Treatments Being Tested
This phase II study is designed to determine the clinical efficacy of PD-1 ...
Status
Recruiting
Location
National Research Oncology Center
Start Date
2024-01-09
Trial ID
NCT06812858
Treatments Being Tested
This is a multi-center, open-label Phase 0 Master Protocol in Australia des...
Status
Withdrawn
Location
Chris O'Brien Lifehouse
Start Date
2021-09-15
Trial ID
NCT04891718
Treatments Being Tested
Children, adolescents, and young adults (CAYA) with relapsed/refractory (R/...
Status
Recruiting
Location
New York Medical College
Start Date
2025-08-07
Trial ID
NCT07013565
Treatments Being Tested
Addition of nivolumab (immune checkpoint inhibitor) to standard chemotherap...
Status
Enrolling By Invitation
Location
Dmitry Rogachev National Research Center
Start Date
2024-09-01
Trial ID
NCT06871007
Treatments Being Tested
This is a randomized non-comparative, multicenter phase II study in patient...
Status
Recruiting
Location
Institut de Cancerologie de L'Ouest Paul Papin
Start Date
2024-04-16
Trial ID
NCT06253611
Treatments Being Tested